UOC
LEGN icon

UBS O'Connor’s Legend Biotech LEGN Stock Holding History

UBS O'Connor’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,000
Closed -$18.5K – 594
2024
Q1 		$18.5K Buy
30,000
+17,500
+140% +$1.06M ﹤0.01% 463
2023
Q4 		$21.6K Buy
+12,500
New +$792K ﹤0.01% 443
2023
Q1 		– Sell
-22,000
Closed -$9K – 678
2022
Q4 		$9K Buy
+22,000
New +$1.07M ﹤0.01% 702

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

UBS O'Connor's LEGN Position: Q2 2021 in Review

UBS O'Connor sold out of Legend Biotech (LEGN) in Q2 2021, closing a stake of 15,000 shares — an estimated $435K sold.

UBS O'Connor first reported a position in LEGN in Q2 2020 and held it in 2 quarters. The position peaked at $2.79M in Q2 2020. 86 funds tracked by Wall St. Rank hold LEGN as of Q2 2021.

  • UBS O'Connor reported no remaining Legend Biotech position as of Q2 2021 after selling out during the quarter.
  • UBS O'Connor sold 15,000 Legend Biotech shares in Q2 2021, an estimated $435K.
  • UBS O'Connor first reported a position in Legend Biotech in Q2 2020 and held it in 2 quarters.
  • UBS O'Connor's Legend Biotech position peaked at $2.79M in Q2 2020.
  • 86 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2021.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.